Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.

Bergeron D, Gorno-Tempini ML, Rabinovici GD, Santos-Santos MA, Seeley W, Miller BL, Pijnenburg Y, Keulen MA, Groot C, van Berckel BNM, van der Flier WM, Scheltens P, Rohrer JD, Warren JD, Schott JM, Fox NC, Sanchez-Valle R, Grau-Rivera O, Gelpi E, Seelaar H, Papma JM, van Swieten JC, Hodges JR, Leyton CE, Piguet O, Rogalsky EJ, Mesulam MM, Koric L, Nora K, Pariente J, Dickerson B, Mackenzie IR, Hsiung GR, Belliard S, Irwin DJ, Wolk DA, Grossman M, Jones M, Harris J, Mann D, Snowden JS, Chrem-Mendez P, Calandri IL, Amengual AA, Miguet-Alfonsi C, Magnin E, Magnani G, Santangelo R, Deramecourt V, Pasquier F, Mattsson N, Nilsson C, Hansson O, Keith J, Masellis M, Black SE, Matías-Guiu JA, Cabrera-Martin MN, Paquet C, Dumuirger J, Teichmann M, Sarazin M, Bottlaender M, Dubois B, Rowe CC, Villemagne VL, Vandenberghe R, Granadillo E, Teng E, Mendez M, Meyer PT, Frings L, Lleó A, Blesa R, Fortea J, Seo SW, Diehl-Schmid J, Grimmer T, Frederiksen KS, Sánchez-Juan P, Chételat G, Jansen W, Bouchard RW, Robert L Jr, Visser PJ, Ossenkoppele R.

Ann Neurol. 2018 Sep 26. doi: 10.1002/ana.25333. [Epub ahead of print]

PMID:
30255971
2.

Amyloid pet in primary progressive aphasia: case series and systematic review of the literature.

Villarejo-Galende A, Llamas-Velasco S, Gómez-Grande A, Puertas-Martín V, Contador I, Sarandeses P, González-Sánchez M, Trincado R, Pilkington P, Ruiz-Solis S, Pérez-Martínez DA, Herrero-San Martín A.

J Neurol. 2017 Jan;264(1):121-130. doi: 10.1007/s00415-016-8324-8. Epub 2016 Nov 4. Review.

PMID:
27815682
3.

Typical and atypical pathology in primary progressive aphasia variants.

Spinelli EG, Mandelli ML, Miller ZA, Santos-Santos MA, Wilson SM, Agosta F, Grinberg LT, Huang EJ, Trojanowski JQ, Meyer M, Henry ML, Comi G, Rabinovici G, Rosen HJ, Filippi M, Miller BL, Seeley WW, Gorno-Tempini ML.

Ann Neurol. 2017 Mar;81(3):430-443. doi: 10.1002/ana.24885. Epub 2017 Mar 20.

4.

Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias.

Steinacker P, Semler E, Anderl-Straub S, Diehl-Schmid J, Schroeter ML, Uttner I, Foerstl H, Landwehrmeyer B, von Arnim CA, Kassubek J, Oeckl P, Huppertz HJ, Fassbender K, Fliessbach K, Prudlo J, Roßmeier C, Kornhuber J, Schneider A, Volk AE, Lauer M, Danek A, Ludolph AC, Otto M; FTLDc Study Group.

Neurology. 2017 Mar 7;88(10):961-969. doi: 10.1212/WNL.0000000000003688. Epub 2017 Feb 8.

PMID:
28179468
5.

Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.

Santos-Santos MA, Rabinovici GD, Iaccarino L, Ayakta N, Tammewar G, Lobach I, Henry ML, Hubbard I, Mandelli ML, Spinelli E, Miller ZA, Pressman PS, O'Neil JP, Ghosh P, Lazaris A, Meyer M, Watson C, Yoon SJ, Rosen HJ, Grinberg L, Seeley WW, Miller BL, Jagust WJ, Gorno-Tempini ML.

JAMA Neurol. 2018 Mar 1;75(3):342-352. doi: 10.1001/jamaneurol.2017.4309.

6.

Neuroimaging and biochemical markers in the three variants of primary progressive aphasia.

Gil-Navarro S, Lladó A, Rami L, Castellví M, Bosch B, Bargalló N, Lomeña F, Reñé R, Montagut N, Antonell A, Molinuevo JL, Sánchez-Valle R.

Dement Geriatr Cogn Disord. 2013;35(1-2):106-17. doi: 10.1159/000346289. Epub 2013 Feb 6.

PMID:
23392204
7.

Slowed articulation rate is a sensitive diagnostic marker for identifying non-fluent primary progressive aphasia.

Cordella C, Dickerson BC, Quimby M, Yunusova Y, Green JR.

Aphasiology. 2017;31(2):241-260. doi: 10.1080/02687038.2016.1191054. Epub 2016 Jul 21.

8.

CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and (11)C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease.

Ikeda M, Tashiro Y, Takai E, Kurose S, Fugami N, Tsuda K, Arisaka Y, Kodaira S, Fujita Y, Makioka K, Mizuno Y, Shimada H, Harigaya Y, Takatama M, Amari M, Yamazaki T, Yamaguchi H, Higuchi T, Okamoto K, Tsushima Y, Ikeda Y.

Amyloid. 2014 Dec;21(4):238-45. doi: 10.3109/13506129.2014.949231. Epub 2014 Aug 20.

PMID:
25139672
9.

Decreased striatal dopamine transporter uptake in the non-fluent/agrammatic variant of primary progressive aphasia.

Gil-Navarro S, Lomeña F, Cot A, Lladó A, Montagut N, Castellví M, Bosch B, Rami L, Antonell A, Balasa M, Pavia J, Iranzo A, Molinuevo JL, Sánchez-Valle R.

Eur J Neurol. 2013 Nov;20(11):1459-e126. doi: 10.1111/ene.12196. Epub 2013 May 17.

PMID:
23679075
10.

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.

Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ; Amyloid PET Study Group, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, Miller BL, Rosen HJ, Landau SM, Villemagne VL, Rowe CC, Lee DY, Na DL, Seo SW, Sarazin M, Roe CM, Sabri O, Barthel H, Koglin N, Hodges J, Leyton CE, Vandenberghe R, van Laere K, Drzezga A, Forster S, Grimmer T, Sánchez-Juan P, Carril JM, Mok V, Camus V, Klunk WE, Cohen AD, Meyer PT, Hellwig S, Newberg A, Frederiksen KS, Fleisher AS, Mintun MA, Wolk DA, Nordberg A, Rinne JO, Chételat G, Lleo A, Blesa R, Fortea J, Madsen K, Rodrigue KM, Brooks DJ.

JAMA. 2015 May 19;313(19):1939-49. doi: 10.1001/jama.2015.4669.

11.

Neuropsychological differentiation of progressive aphasic disorders.

Harris JM, Saxon JA, Jones M, Snowden JS, Thompson JC.

J Neuropsychol. 2018 Feb 8. doi: 10.1111/jnp.12149. [Epub ahead of print]

PMID:
29424041
12.

Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia.

Santangelo R, Coppi E, Ferrari L, Bernasconi MP, Pinto P, Passerini G, Comi G, Magnani G.

J Alzheimers Dis. 2015;43(4):1429-40. doi: 10.3233/JAD-141122.

PMID:
25201781
13.

Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease.

Louwersheimer E, Keulen MA, Steenwijk MD, Wattjes MP, Jiskoot LC, Vrenken H, Teunissen CE, van Berckel BN, van der Flier WM, Scheltens P, van Swieten JC, Pijnenburg YA.

J Alzheimers Dis. 2016;51(2):581-90. doi: 10.3233/JAD-150812.

PMID:
26890751
14.

Is descriptive writing useful in the differential diagnosis of logopenic variant of primary progressive aphasia, Alzheimer's disease and mild cognitive impairment?

Sitek EJ, Barczak A, Kluj-Kozłowska K, Kozłowski M, Barcikowska M, Sławek J.

Neurol Neurochir Pol. 2015;49(4):239-44. doi: 10.1016/j.pjnns.2015.06.001. Epub 2015 Jun 17.

PMID:
26188940
15.

Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.

Ramanan S, Flanagan E, Leyton CE, Villemagne VL, Rowe CC, Hodges JR, Hornberger M.

J Alzheimers Dis. 2016;51(2):367-76. doi: 10.3233/JAD-150752.

PMID:
26890745
16.

Neuroimaging in the differential diagnosis of primary progressive aphasia - illustrative case series in the light of new diagnostic criteria.

Sitek EJ, Narożańska E, Brockhuis B, Muraszko-Klaudel A, Lass P, Harciarek M, Sławek J.

Pol J Radiol. 2014 Aug 8;79:251-8. doi: 10.12659/PJR.890320. eCollection 2014.

17.

Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia.

Paraskevas GP, Kasselimis D, Kourtidou E, Constantinides V, Bougea A, Potagas C, Evdokimidis I, Kapaki E.

J Alzheimers Dis. 2017;55(4):1453-1461. doi: 10.3233/JAD-160494.

PMID:
27858708
18.

Differentiating between subtypes of primary progressive aphasia and mild cognitive impairment on a modified version of the Frontal Behavioral Inventory.

Tippett DC, Thompson CB, Demsky C, Sebastian R, Wright A, Hillis AE.

PLoS One. 2017 Aug 16;12(8):e0183212. doi: 10.1371/journal.pone.0183212. eCollection 2017.

19.

Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia.

Giannini LAA, Irwin DJ, McMillan CT, Ash S, Rascovsky K, Wolk DA, Van Deerlin VM, Lee EB, Trojanowski JQ, Grossman M.

Neurology. 2017 Jun 13;88(24):2276-2284. doi: 10.1212/WNL.0000000000004034. Epub 2017 May 17.

20.

Patterns of breakdown in spelling in primary progressive aphasia.

Sepelyak K, Crinion J, Molitoris J, Epstein-Peterson Z, Bann M, Davis C, Newhart M, Heidler-Gary J, Tsapkini K, Hillis AE.

Cortex. 2011 Mar;47(3):342-52. doi: 10.1016/j.cortex.2009.12.001. Epub 2009 Dec 22.

Supplemental Content

Support Center